EDAP’s new complete urology platform combines a fully dedicated endourology table with X-ray and Ultrasound imaging systems, an integrated shockwave generator and an Holmium laser source
Image: Endo-UP is a new conceptual product designed for the management of urinary stones. Photo: Courtesy of Mériele Oliveira Méri from Pixabay.
EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in therapeutic ultrasound, announced today the introduction of a new concept of Endourology Platform during the WCE congress, which is being held in Abu Dhabi, October 29 – November 2, 2019.
Endo-UP is a new conceptual product designed for the management of urinary stones. Responding to the rapidly evolving urinary stone treatment paradigm, EDAP’s new complete urology platform combines a fully dedicated endourology table with X-ray and Ultrasound imaging systems, an integrated shockwave generator and an Holmium laser source. This unique all-in-one concept will allow surgeons to choose from among multiple stone treatment strategies, including Extracorporeal Shockwave Lithotripsy (ESWL), Ureteroscopy (URS), Percutaneous Nephrolithotomy (PCNL), or even a combination of therapeutic approaches. The idea of having all the tools instantaneously available to surgeons, and providing surgeons with the ability to select the best approach or combination of approaches depending on the patient and the stone represents a true breakthrough in the management of urinary stones.
Marc Oczachowski, EDAP’s Chief Executive Officer, said: “We are proud to introduce another innovation to urologists and their patients. Our company is a world-renowned leader in urinary stone management with nearly 40 years of expertise in Extracorporeal Shockwave Lithotripsy, having introduced ten generations of devices and sold more than 1,000 units worldwide. The global urinary stone market is growing rapidly, and the unique concept of Endo-UP, including its exclusive multi-modality platform, will allow us to gain market share while at the same time pioneering a new and revolutionary way of efficiently managing stone disease globally.”
For 40 years, EDAP has been a leading innovator in the treatment of urinary stones market, regularly introducing new lithotripters. Today, the company is leveraging its expertise to develop new tools that address the current clinical and financial needs of hospitals and surgeons.
Source: Company Press Release